Bk polyomavirus nephropathy in kidney transplantation: Balancing rejection and infection

Chia Lin Shen, Bo Sheng Wu, Tse Jen Lien, An Hang Yang, Chih Yu Yang*

*此作品的通信作者

研究成果: Review article同行評審

30 引文 斯高帕斯(Scopus)

摘要

BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated diseases on opposite ends of the immune scale in kidney transplant recipients. The principle of balancing the immune system remains the mainstay of therapeutic strategy. While patient outcomes can be improved through screening, risk factors identification, and rapid reduction of immunosuppressants, a lack of standard curative therapy is the primary concern during clinical practice. Additionally, difficulty in pathological differential diagnosis and clinicopathology’s dissociation pose problems for a definite diagnosis. This article discusses the delicate evaluation needed to optimize immunosuppression and reviews recent advances in molecular diagnosis and immunological therapy for BKVN patients. New biomarkers for BKVN diagnosis are under development. For example, measurement of virus-specific T cell level may play a role in steering immunosuppressants. The development of cellular therapy may provide prevention, even a cure, for BKVN, a complex post-transplant complication.

原文English
文章編號487
期刊Viruses
13
發行號3
DOIs
出版狀態Published - 3月 2021

指紋

深入研究「Bk polyomavirus nephropathy in kidney transplantation: Balancing rejection and infection」主題。共同形成了獨特的指紋。

引用此